Crinetics Pharmaceuticals Inc Earnings

Crinetics Pharmaceuticals Inc’s revenue jumped 158.4% since last year same period to $1.03Mn in the Q2 2025. On a quarterly growth basis, Crinetics Pharmaceuticals Inc has generated 185.6% jump in its revenue since last 3-months.

Crinetics Pharmaceuticals Inc’s net profit fell -56.15% since last year same period to $-115.64Mn in the Q2 2025. On a quarterly growth basis, Crinetics Pharmaceuticals Inc has generated -19.49% fall in its net profits since last 3-months.

Crinetics Pharmaceuticals Inc’s net profit margin jumped 39.57% since last year same period to -11216% in the Q2 2025. On a quarterly growth basis, Crinetics Pharmaceuticals Inc has generated 58.16% jump in its net profit margins since last 3-months.

Crinetics Pharmaceuticals Inc’s earning per share (EPS) estimates for the current quarter stand at -1.16 - a -5.45% fall from last quarter’s estimates.

Crinetics Pharmaceuticals Inc’s earning per share (EPS) estimates for the current year stand at -1.16.

Crinetics Pharmaceuticals Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2025. This indicates that the Crinetics Pharmaceuticals Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.